Related to Lilly Plans €330M Expansion of Manufacturing Site in Kinsale, Ireland

• Lilly to Invest Millions into Multispecific Therapeutics R&D
  
• Shimadzu UK Opens Evaluation Laboratory to Bolster Use of Customized Application Solutions
  
• Gilead to Buy Biologics Facility in California from Genentech
  
• Promega Plans 260,000-Square-Foot Facility for Molecular Bio Products
  
• BI and Lilly’s Linagliptin Now Approved to Treat Type 2 Diabetes in Europe
  
• Qiagen and Lilly to Co-Develop Companion Diagnostic for JAK2 Inhibitor Candidate
  
• Hikma Buys 63.9% Stake in Morocco’s Promopharm as Start of Takeover Bid
  
• NIPTE Receives $35M from FDA to Reform Drug Manufacturing Standards
  
• FDA Clears Lilly’s Cialis for Treating Symptoms of BPH in Men with or without Erectile Dysfunction
  
• Venture Firms Pump $18M into Fledgling Arteaus Therapeutics
  
• Lilly Pulls Septic Shock Drug Xigris Off the Shelves
  
• SurModics Sells Pharmaceutical Assets to Evonik for $30M
  
• Amylin to Pay Lilly $250M to End Exenatide Partnership and Litigation
  
• Elan, Cambridge University Launch CNS Disease Drug Discovery Facility
  
• Xceleron Raises $2.4M to Relocate to Facility Offering AMS, LC-MS/MS Services
  
• U.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny
  
• Medicago Achieves Fourth Milestone in Setting Up U.S. cGMP Facility for Plant-Expressed Vaccines
  
• Ireland's Leadership in Pharma Exports Clouded by Industry Challenges
  
• Velesco to Manufacture Rubicon’s TransPLEX Amplification Kits for Supply to Agendia
  
• Recipharm Contracted for Commercial Manufacture of ViroPharma’s Plenadren